Dallas-based United Surgical Partners International, a subsidiary of Tenet Healthcare, reported year-over-year revenue gains in the third quarter, according to financial results released Oct. 20.
Oral anticancer drugs are an increasingly prescribed form of treatment. However, studies found that 10 percent to 20 percent of patients never received the prescription, and New York-based researchers set out to discover why.
Twenty-six United Surgical Partners International ASCs made Newsweek’s “America’s Best Ambulatory Surgery Centers,” which ranks 510 of the more than 5,000 Medicare-certified ASCs in the country.